Role of magnetic resonance spectroscopic imaging (MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer in patients with prior negative prostate biopsy and high PSA levels: results from a single-centre, prospective series

Umberto Anceschi¹, Alessandra Pizzo², Carlo Molinari¹, Giovanni Regine³, Carlo Parola¹, Massimo Governatori¹, Pasquale Gambardella¹, Claudio Anceschi¹

¹ Ospedale San Camillo-Forlanini, U.O.C. Urologia (Roma)
² Università degli Studi, U.O.C. Ginecologia (Siena)
³ Ospedale San Camillo-Forlanini, U.O.C. Radiologia (Roma)

Argomenti: cancro della prostata

Role of magnetic resonance spectroscopic imaging (MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer in patients with prior negative prostate biopsy and high PSA levels: results from a single-centre, prospective series

Pagine

Auro.it – Associazione Urologi Italiani